Phenotypic Precision Medicine in Advanced Prostate Cancer Knowledge Hub

Dr. Ofer Sharon, CEO of OncoHost, Talks the Potential Impact of Precision Medicine on...

November 15, 2021

Dr. Ofer Sharon is a physician and entrepreneur with 17+ years of experience in the oncology drug development industry and CEO of OncoHost. Ofer is leading...

Dr. Ofer Sharon, CEO of OncoHost, Talks the Potential Impact of Precision Medicine on...

November 15, 2021

Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-Positive Prostate Cancer

November 5, 2021

Detecting and Grading Prostate Cancer in Radical Prostatectomy Specimens Through Deep Learning

November 5, 2021

Machine Learning Algorithm Predicts Short-Term Cancer Mortality in Outpatients

An Artificial Intelligence-Powered Platform for Prostate Cancer Grading

November 5, 2021

Has the COVID-19 Outbreak Changed Prostate Cancer Treatment?

November 5, 2021

Molecular Profiling in Precision Medicine in Prostate Cancer

November 3, 2021

Curated Journal reading List

Does prior transurethral resection of prostate affect the functional and oncological outcomes of robot-assisted...

November 28, 2021

Does prior transurethral resection of prostate affect the functional and oncological outcomes of robot-assisted...

November 28, 2021

Does prior transurethral resection of prostate affect the functional and oncological outcomes of robot-assisted...

November 28, 2021

Oncological and functional outcomes of extraperitoneal laparoscopic radical prostatectomy: An 18-years, single-center experience

November 29, 2021

Visceral adiposity is associated with worse urinary and sexual function recovery after radical prostatectomy:...

November 29, 2021

The presence of chronic inflammation in positive prostate biopsy is associated with upgrading in...

November 29, 2021

Stereotactic Body Radiation Therapy (SBRT) for prostate cancer: Preliminary results of toxicity

November 29, 2021

Association of metabolic syndrome with prostate cancer diagnosis and aggressiveness in patients undergoing transrectal...

November 29, 2021

Potential prognostic value of miR-132 and miR-212 expression in mCRPC patients

November 29, 2021

A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with...

November 29, 2021

Expert Interviews

Dr. Berchuck Discusses Androgen Indifferent Prostate Cancer

June 30, 2021

Dr. Agarwal Discusses DNA Damage Repair Mutations in Prostate Cancer

May 27, 2021

Dr. Berchuck Discusses LuPSMA, Molecular Imaging in Prostate Cancer

July 1, 2021